Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-07-12 Sale |
2023-07-14 4:00 pm |
Taysha Gene Therapies Inc. | TSHA | Session R.A. II 10% Owner |
85,872 | $0.70769 | $60,771 | 9,153,927 (Indirect Direct) |
View |
| 2023-06-22 Sale |
2023-06-26 4:46 pm |
Taysha Gene Therapies Inc. | TSHA | Session R.A. II 10% Owner |
28,608 | $0.70327 | $20,119 | 9,239,799 (Indirect Direct) |
View |
| 2023-06-20 Sale |
2023-06-22 4:00 pm |
Taysha Gene Therapies Inc. | TSHA | Session R.A. II 10% Owner |
434,615 | $0.70831 | $307,844 | 9,268,407 (Indirect Direct) |
View |
| 2021-11-23 Purchase |
2021-12-08 4:05 pm |
Taysha Gene Therapies Inc. | TSHA | Session R.A. II President and CEO 10% Owner |
42,518 | $12.44 | $529,102 | 9,473,100 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-06 Other |
2023-03-08 7:38 pm |
N/A N/A |
Taysha Gene Therapies Inc. | TSHA | Session R.A. II 10% Owner |
251,296 | $0 | 9,954,318 (Direct) |
View |
| 2022-11-10 Option Award |
2022-12-23 4:15 pm |
N/A 2032-11-10 |
Taysha Gene Therapies Inc. | TSHA | Session R.A. II Director 10% Owner |
199,500 | $0 | 199,500 (Direct) |
View |
| 2022-02-23 Option Award |
2022-02-25 4:17 pm |
N/A 2032-02-23 |
Taysha Gene Therapies Inc. | TSHA | Session R.A. II President and CEO 10% Owner |
217,850 | $0 | 217,850 (Direct) |
View |
| 2021-01-19 Option Award |
2021-01-20 8:22 pm |
N/A 2031-01-19 |
Taysha Gene Therapies Inc. | TSHA | Session R.A. II President and CEO 10% Owner |
199,700 | $0 | 199,700 (Direct) |
View |
Ownership |
2020-09-23 8:32 pm |
N/A N/A |
Taysha Gene Therapies Inc. | TSHA | Session R.A. II President and CEO 10% Owner |
0 | $0 | 9,430,582 (Direct) |
View |